POINT

Jul 16 2025SPORTS

WNBA Stars Aim for Three-Point Glory

The spotlight is on some of the WNBA's best shooters as they prepare to compete in the 3-Point Contest this Friday. Caitlin Clark, the rising star from the Indiana Fever, will be there, aiming to make her mark in her first-ever contest. She's up against some tough competition, including Sabrina Ione

reading time less than a minute
Jul 10 2025SCIENCE

A New Leader for Pulmonary Pharmacology & Therapeutics

Mario Cazzola has taken on a new role as an honorary editor for the journal Pulmonary Pharmacology & Therapeutics. This is a big deal because it means he gets to help shape the future of research in this field. But what does this really mean for the world of respiratory medicine? First, let's talk

reading time less than a minute
Jul 03 2025BUSINESS

A Guitar Pedal Maker's Clever Way to Beat Tariff Trouble

In the world of small businesses, finding creative solutions to big problems is key. One such business, Keeley Electronics, has been hit hard by U. S. tariffs on imports from China. The company, which makes guitar pedals, relies on a specific component called a potentiometer, which can only be sourc

reading time less than a minute
Jul 02 2025HEALTH

Why Just One More Thing Can Be a Big Problem for Doctors

Doctors have a lot on their plates. They see many patients in a day, and each visit is packed with important health discussions. But there's a common phrase that can throw a wrench into their schedules: "Just one more thing. " This simple phrase often pops up at the end of an appointment, when the d

reading time less than a minute
Jun 25 2025HEALTH

Why Glioblastoma Fights Back Against Checkpoint Inhibitors

Glioblastoma, a tough brain cancer, has been a hard nut to crack for doctors. They've tried a treatment called checkpoint inhibitor therapy (CPI). It has worked wonders for other cancers. But for glioblastoma, it's not been as effective. Why is that? Scientists are digging deep to find out. They're

reading time less than a minute
Jun 24 2025POLITICS

Big Ad Deal Gets Green Light with a Twist

A huge ad deal just got the okay from the Federal Trade Commission (FTC), but there's a catch. The FTC, currently all Republican, said yes to Omnicom buying Interpublic Group for $13. 5 billion. But they added a rule: Omnicom can't steer ads away from platforms based on political views. This means O

reading time less than a minute
Jun 20 2025HEALTH

New Hope for Bile Duct Cancer Patients

Bile duct cancers are a tough bunch to beat. They are tricky because they come in different forms and are hard to treat. For a long time, doctors have used a combo of gemcitabine and cisplatin to help patients feel better, even if it couldn't cure them. This was the go-to treatment for over ten year

reading time less than a minute
Jun 18 2025POLITICS

Jared's Unseen Path: A Vision for NASA's Future

Jared Isaacman had a plan. He was close to becoming NASA's administrator. He had gone through months of checks, interviews, and a committee hearing. He was all set for a vote in the US Senate. Then, a phone call changed everything. The president's office wanted a different person for the job. This w

reading time less than a minute
Jun 18 2025POLITICS

A Sudden Health Scare for a Key Official

Kristi Noem, the current Homeland Security Secretary, faced a sudden health issue recently. She was rushed to a hospital in the Washington, DC, area after experiencing an allergic reaction. This event happened on a Tuesday and was confirmed by the Department of Homeland Security. Noem is 53 years ol

reading time less than a minute
Jun 17 2025HEALTH

Nanotech and Magnetism: A New Hope in Cancer Treatment

Cancer treatment has seen a big change with immune checkpoint blockade (ICB) therapy. This therapy works by waking up the body's immune system to fight cancer. However, it doesn't always work well with solid tumors. The immune response might not be strong enough. To tackle this, scientists have come

reading time less than a minute